MedTrace Logo

Belgian Prospective Multicentre Registry to Evaluate Safety and Performance of the Optimed Stent in the Superficial Femoral Artery

NCT01499342 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 435

Last updated 2022-08-22

No results posted yet for this study

Summary

This is a Belgian prospective multicentre registry to evaluate safety and performance of the Sinus-Superflex-Visual stent (Optimed) in Superficial Femoral Artery (SFA) atherosclerotic lesions. Target number is 500 patients in approximately 11 centres. Patients will be followed for a period of 2 years.

Conditions

  • Peripheral Arterial Disease

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    collaborator OTHER

  • Ziekenhuis Oost-Limburg

    collaborator OTHER

  • be Medical

    lead INDUSTRY

Principal Investigators

  • Sabrina Houthoofd, MD · Universitaire Ziekenhuizen KU Leuven

  • Herman Schroë, MD · Ziekenhuis Oost-Limburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01499342 on ClinicalTrials.gov